Journal
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Volume 1211, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jchromb.2022.123500
Keywords
Ultrafast affinity extraction; Drug-protein binding; Human serum albumin; Advanced glycation end products; Warfarin
Funding
- National Science Foundation under grant [CMI 2108881]
- National Institutes of Health [R01 DK069629]
Ask authors/readers for more resources
Ultrafast affinity extraction and affinity microcolumns were used to evaluate the effect of advanced stage glycation on HSA and its binding to warfarin. The results showed that MGO-modified HSA had higher association equilibrium constants with warfarin compared to normal HSA, while GO-modified HSA had similar values.
Ultrafast affinity extraction (UAE) and affinity microcolumns containing immobilized human serum albumin (HSA) were employed to evaluate the effect of advanced stage glycation on HSA and its binding to warfarin, a common site-specific probe for Sudlow site I of this protein. The modification of HSA by glyoxal (GO) and methylglyoxal (MGO) was considered, where GO and MGO are known to be important in the formation of many types of advanced glycation end products. Free drug fractions were measured by UAE for warfarin in solutions containing normal HSA or HSA that had been modified by GO or MGO at levels seen in serum during diabetes. The free fractions measured with the GO-modified HSA gave association equilibrium constants that ranged from 2.42-2.63 x 105 M-1 at pH 7.4 and 37 degrees C. These values were not significantly different from a value of 2.33 (+/- 0.15) x 105 M-1 that was determined by the same method for warfarin with normal HSA. Similar studies using MGO-modified HSA gave association equilibrium constants for warfarin in the range of 3.07-3.31 x 105 M-1, which were 1.32- to 1.42-fold higher than the value seen for normal HSA (differences that were significant at the 95% confidence level). These results will be valuable in future binding studies based on affinity chromatography or other methods that employ warfarin as a probe to examine drug interactions at Sudlow site I of HSA and modified forms of this protein. This work also illustrates how UAE can be used, with analysis times of only minutes, to detect and measure small changes in the binding by drugs with unmodified or modified forms of a soluble binding agent or protein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available